Home | Welcome to Contract Pharma   
Last Updated Tuesday, September 30 2014
Print

Search Results for 'biotech'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published April 9, 2012
Will be responsible for development and commercialization Read More »
Published May 12, 2011
Oncolytics Biotech has entered into a commercial supply agreement with SAFC, a division of Sigma-Aldrich Corp., for the commercial manufacture of Oncolytics’ reovirus, Reolysin. Read More »
Published October 14, 2010
Dr. Christel Fenge has been named vice president of marketing for Fermentation Technologies at Sartorius Stedim Biotech. Read More »
Published July 29, 2010
Aptuit, Inc. and Siena Biotech entered into a strategic partnership under which Siena Biotech will take a minority stake in Aptuit’s operations in Verona, Italy and Aptuit will serve as Siena’s provider of choice for its development pipeline. Read More »
Published February 8, 2010
Teva Pharmaceutical Industries, Ltd. and Active Biotech have amended their marketing and distribution agreement for oral laquinimod, an investigational drug for relapsing-remitting multiple sclerosis (RRMS). Read More »
Published October 30, 2009
Eli Lilly and Co. has opened its new Biotechnology Center in San Diego, as part of its strategy to develop more biopharmaceuticals. Read More »
Published June 12, 2009
Dr. Yujing Yang has assumed the position of director of Purification Technologies, North America, at Sartorius Stedim Biotech. Read More »
Published May 12, 2009
Sartorius Stedim Biotech expanded its technology portfolio with the addition of two prototypes of single-use bioreactors that operate based on novel mixing technologies. Read More »
Published November 12, 2008
Merck Serono recently held a cornerstone ceremony at the Merck Serono Biotech Center (MSBC), its production site in Corsiersur-Vevey, Switzerland, to mark the expansion of the site. The expansion will enable the production of greater quantities of Er… Read More »
Published October 31, 2008
Sartorius Stedim Biotech GmbH (SSB) signed an agreement to acquire the Swiss-based technology company Wave Biotech AG. The two companies have been working together since 2006 on joint research projects. SSB has been exclusively marketing Wave's pro… Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On